FULCRUM THERAPEUTICS INC (FULC) Stock News

USA - NASDAQ:FULC - US3596161097 - Common Stock

9.125 USD

-0.57 (-5.93%)

Last: 10/22/2025, 11:46:44 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FULC Latest News, Press Relases and Analysis

All

Press Releases

3 hours ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET

3 hours ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET

8 days ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025

8 days ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025

12 days ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 days ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Benzinga - Mentions: XRTX DRIO MTNB CTMX ...

12 Health Care Stocks Moving In Thursday's After-Market Session

a month ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present at Upcoming Investor Meetings

2 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present at Upcoming Investor Meetings

2 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Benzinga - Mentions: STX CAR EDU TAL ...

Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present at Upcoming Medical Meetings

5 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Present at Upcoming Medical Meetings

5 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

6 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Participate in Upcoming May Conferences